Related Experiment Video
Updated: Jan 20, 2026

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Screening protocol for the identification of modulators by immunofluorescent cell-based assay
Javier Klett1, Elena Gómez-Casero1, Marinela Méndez-Pertuz2
1Experimental Therapeutics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
We developed an automated platform to quantify nuclear foci, assessing compound inhibition of target proteins. This high-content screening system provides reliable, user-friendly analysis for drug discovery.
Area of Science:
- Biochemistry
- Cell Biology
- Drug Discovery
Background:
- High-throughput assays are crucial for identifying compounds that modulate cellular activity.
- Quantifying target protein modulation often involves complex imaging and analysis.
Purpose of the Study:
- To present an automated analysis platform for quantifying nuclear foci to assess compound inhibition.
- To integrate cell-based assays, high-content screening, and confocal microscopy with automated statistical analysis.
Main Methods:
- Developed an automated platform combining cell-based assays, high-content screening, and confocal microscopy.
- Implemented a web-based tool using Pipeline Pilot and R for statistical analysis.
- Included positive and negative controls and calculated Z-prime and Window values for assay reliability.
Main Results:
- The platform quantifies nuclear foci, indicating compound inhibitory effects on target proteins.
- It computes inhibition values based on various parameters (e.g., foci number, intensity, area).
- Provides outlier detection, filtering, and comprehensive statistical plots for result interpretation.
Conclusions:
- The automated platform offers a fast, user-friendly, and reliable method for analyzing compound inhibition via nuclear foci.
- It facilitates efficient exploration of screening data, aiding in the interpretation of assay results.
- This system enhances the process of identifying potential therapeutic compounds in drug discovery pipelines.
Related Concept Videos
07:39SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
09:44High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:15DNA-based Fish Species Identification Protocol
13:59High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
15:29Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells
10:30A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

